Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$82.2M |
| 2 |
Conagra Brands
CAG
|
+$63.5M |
| 3 |
Intuit
INTU
|
+$53.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$51.9M |
| 5 |
CVS Health
CVS
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$40.5M |
| 2 |
Merck
MRK
|
+$39.5M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$38.8M |
| 4 |
Viatris
VTRS
|
+$38.8M |
| 5 |
DaVita
DVA
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Industrials | 19.34% |
| 3 | Healthcare | 18.39% |
| 4 | Consumer Discretionary | 16.87% |
| 5 | Consumer Staples | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Xencor
XNCR
$2.16B
| $443K | 0.01% |
+23,338
| New | +$320K |
|
752
Manhattan Associates
MANH
$12.4B
| $436K | 0.01% |
6,800
-18,494
| -73% | -$1.15M |
|
753
AAR Corp
AIR
$5.42B
| $426K | 0.01% |
18,272
+6,465
| +55% | +$153K |
|
754
MYR Group
MYRG
$4.75B
| $424K | 0.01% |
+17,603
| New | +$429K |
|
755
Xylem
XYL
$26.7B
| $424K | 0.01% |
9,494
-209,936
| -96% | -$9.12M |
|
756
CAE Inc
CAE
$7.96B
| $422K | 0.01% |
34,903
-7,297
| -17% | -$88.1K |
|
|
AVTA
757
DELISTED
Avantax, Inc. Common Stock
AVTA
| $418K | 0.01% |
+40,352
| New | +$317K |
|
758
Murphy Oil
MUR
$5.16B
| $413K | 0.01% |
+13,020
| New | +$394K |
|
759
ANI Pharmaceuticals
ANIP
$1.7B
| $409K | ﹤0.01% |
7,324
-4,364
| -37% | -$212K |
|
760
Encompass Health
EHC
$11.9B
| $408K | ﹤0.01% |
+13,196
| New | +$413K |
|
|
NXTM
761
DELISTED
NxStage Medical Inc.
NXTM
| $407K | ﹤0.01% |
+18,781
| New | +$335K |
|
762
Eaton
ETN
$159B
| $406K | ﹤0.01% |
6,795
-322,145
| -98% | -$19.8M |
|
763
H.B. Fuller
FUL
$3.12B
| $405K | ﹤0.01% |
9,207
-103,415
| -92% | -$4.64M |
|
764
Amphenol
APH
$192B
| $399K | ﹤0.01% |
27,840
-850,264
| -97% | -$12.2M |
|
|
ASNA
765
DELISTED
Ascena Retail Group, Inc.
ASNA
| $399K | ﹤0.01% |
+2,852
| New | +$462K |
|
766
Moody's
MCO
$88.6B
| $396K | ﹤0.01% |
4,224
+1,992
| +89% | +$192K |
|
|
MDSO
767
DELISTED
Medidata Solutions, Inc.
MDSO
| $388K | ﹤0.01% |
+8,271
| New | +$360K |
|
768
GoDaddy
GDDY
$12.7B
| $384K | ﹤0.01% |
12,311
-26,420
| -68% | -$828K |
|
|
NPTN
769
DELISTED
NEOPHOTONICS CORP
NPTN
| $384K | ﹤0.01% |
+40,333
| New | +$439K |
|
|
OCLR
770
DELISTED
Oclaro Inc.
OCLR
| $383K | ﹤0.01% |
+78,458
| New | +$390K |
|
771
KB Home
KBH
$3.41B
| $376K | ﹤0.01% |
24,735
-596,939
| -96% | -$8.34M |
|
772
Strategic Education
STRA
$1.87B
| $372K | ﹤0.01% |
7,577
-3,329
| -31% | -$157K |
|
773
Halliburton
HAL
$28.9B
| $370K | ﹤0.01% |
+8,179
| New | +$336K |
|
774
Sensata Technologies
ST
$6.11B
| $370K | ﹤0.01% |
+10,616
| New | +$388K |
|
|
JCP
775
DELISTED
J.C. Penney Company, Inc.
JCP
| $367K | ﹤0.01% |
41,294
-1,011,125
| -96% | -$8.88M |
|
Similar funds
Joel Greenblatt's Q2 2016 Portfolio in Review
As of Q2 2016, Joel Greenblatt held 1,194 positions worth $8.34B, down 6.5% from $8.92B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Joel Greenblatt withdrew a net $527M in Q2 2016, closing 260 positions and reducing 357 holdings. Its most notable exit was Viatris, an estimated $38.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Twenty-First Century Fox, Inc. Class A worth $76.3M.
- Joel Greenblatt's largest Q2 2016 buy was Twenty-First Century Fox, Inc. Class A: 2,822,168 shares worth $76.3M.
- Joel Greenblatt added most to Paramount Global Class B in Q2 2016, an estimated $51.9M increase.
- Joel Greenblatt's biggest Q2 2016 reduction was Texas Instruments, cutting an estimated $40.5M.
- Joel Greenblatt fully exited Viatris in Q2 2016, selling an estimated $38.8M.
- Joel Greenblatt's ten largest holdings make up 9% of its $8.34B portfolio in Q2 2016.
- Joel Greenblatt opened 244 new positions and closed 260 in Q2 2016.
- Joel Greenblatt's portfolio value fell 6.5% quarter-over-quarter to $8.34B.
Based on Gotham Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.